A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

Conditions

• Primary Myelofibrosis
• Anemia

Interventions

• DRUG: Luspatercept

Sponsor

Celgene